{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T10:45:13Z","timestamp":1795085113213,"version":"4.10.2"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T00:00:00Z","timestamp":1504051200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Intrahepatic cholestasis induced by drug toxicity, bile salt export pump (BSEP) deficiency, or pregnancy frequently causes cholestatic liver damage, which ultimately may lead to liver fibrosis and cirrhosis. Here, the preventive and therapeutic effects of peroxisome proliferator-activated receptor \u03b1 (PPAR\u03b1) signaling activated by fenofibrate was evaluated on cholestatic liver damage. Metabolomic analysis revealed that alpha-naphthyl isothiocyanate (ANIT)-induced intrahepatic cholestasis resulted in the accumulation of serum long-chain acylcarnitines and triglyceride, and the reduced expression of four fatty acid <jats:italic>\u03b2<\/jats:italic>-oxidation (<jats:italic>\u03b2<\/jats:italic>-FAO) relevant genes (Cpt1b, Cpt2, Mcad and Hadha), indicating the disruption of <jats:italic>\u03b2-<\/jats:italic>FAO. The increase of acylcarnitines in hepatic cell resulted in the enhanced expression of anti-oxidative genes glutathione S-transferases (Gsta2 and Gstm3) directly. As direct PPAR\u03b1-regulated genes, Cpt1b, Cpt2, and Mcad were up-regulated after pretreatment with PPAR\u03b1 agonist, fenofibrate, indicating the improvement of <jats:italic>\u03b2-<\/jats:italic>FAO. In the end, the disrupted bile acid metabolism in the enterohepatic circulation and the enhanced oxidative stress and inflammation cytokines induced by ANIT exposure were significantly recovered with the improvement of <jats:italic>\u03b2-<\/jats:italic>FAO using fenofibrate treatment. These findings provide the rationale for the use of PPAR\u03b1 agonists as therapeutic alternatives for cholestatic liver damage.<\/jats:p>","DOI":"10.1038\/s41598-017-10524-6","type":"journal-article","created":{"date-parts":[[2017,8,24]],"date-time":"2017-08-24T10:12:38Z","timestamp":1503569558000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["PPAR\u03b1 activation protects against cholestatic liver injury"],"prefix":"10.1038","volume":"7","author":[{"given":"Qi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan-Dan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,30]]},"reference":[{"key":"10524_CR1","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1002\/hep.27744","volume":"62","author":"NS Ghonem","year":"2015","unstructured":"Ghonem, N. S., Assis, D. N. & Boyer, J. L. Fibrates and cholestasis. Hepatology \n                           62, 635\u2013643 (2015).","journal-title":"Hepatology"},{"key":"10524_CR2","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/liv.13294","volume":"37","author":"D Chascsa","year":"2017","unstructured":"Chascsa, D., Carey, E. J. & Lindor, K. D. Old and new treatments for primary biliary cholangitis. Liver Int. \n                           37, 490\u2013499 (2017).","journal-title":"Liver Int."},{"key":"10524_CR3","doi-asserted-by":"publisher","first-page":"24784","DOI":"10.1074\/jbc.M111.329318","volume":"287","author":"Y Zhang","year":"2012","unstructured":"Zhang, Y. et al. Abcb11 deficiency induces cholestasis coupled to impaired beta-fatty acid oxidation in mice. J. Biol. Chem. \n                           287, 24784\u201324794 (2012).","journal-title":"J. Biol. Chem."},{"key":"10524_CR4","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/tx800464q","volume":"22","author":"C Chen","year":"2009","unstructured":"Chen, C., Krausz, K. W., Shah, Y. M., Idle, J. R. & Gonzalez, F. J. Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity. Chem. Res. Toxicol. \n                           22, 699\u2013707 (2009).","journal-title":"Chem. Res. Toxicol."},{"key":"10524_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0163-7258(95)00012-6","volume":"67","author":"B Fromenty","year":"1995","unstructured":"Fromenty, B. & Pessayre, D. Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacol. Ther. \n                           67, 101\u2013154 (1995).","journal-title":"Pharmacol. Ther."},{"key":"10524_CR6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00018-003-3216-3","volume":"61","author":"S Mandard","year":"2004","unstructured":"Mandard, S., Muller, M. & Kersten, S. Peroxisome proliferator-activated receptor alpha target genes. Cell Mol. Life Sci. \n                           61, 393\u2013416 (2004).","journal-title":"Cell Mol. Life Sci."},{"key":"10524_CR7","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1194\/jlr.M027433","volume":"53","author":"F Li","year":"2012","unstructured":"Li, F., Patterson, A. D., Krausz, K. W., Tanaka, N. & Gonzalez, F. J. Metabolomics reveals an essential role for peroxisome proliferator-activated receptor alpha in bile acid homeostasis. J. Lipid Res. \n                           53, 1625\u20131635 (2012).","journal-title":"J. Lipid Res."},{"key":"10524_CR8","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/bph.13729","volume":"174","author":"H Zeng","year":"2017","unstructured":"Zeng, H. et al. Schisandrol B protects against cholestatic liver injury through pregnane X receptors. Br. J. Pharmacol. \n                           174, 672\u2013688 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"10524_CR9","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nm.3104","volume":"19","author":"F Li","year":"2013","unstructured":"Li, F. et al. Human PXR modulates hepatotoxicity associated with rifampicin and isoniazid co-therapy. Nat. Med. \n                           19, 418\u2013420 (2013).","journal-title":"Nat. Med."},{"key":"10524_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/srep33102","volume":"6","author":"J-H Ye","year":"2016","unstructured":"Ye, J.-H. et al. Pentoxifylline ameliorates non-alcoholic fatty liver disease in hyperglycaemic and dyslipidaemic mice by upregulating fatty acid \u03b2-oxidation. Sci. Rep. \n                           6, 33102 (2016).","journal-title":"Sci. Rep."},{"key":"10524_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/srep33052","volume":"6","author":"F Yang","year":"2016","unstructured":"Yang, F. et al. Curcumin protects ANIT-induced cholestasis through signaling pathway of FXR-regulated bile acid and inflammation. Sci. Rep. \n                           6, 33052 (2016).","journal-title":"Sci. Rep."},{"key":"10524_CR12","doi-asserted-by":"publisher","first-page":"2340","DOI":"10.1194\/jlr.R900012-JLR200","volume":"50","author":"PA Dawson","year":"2009","unstructured":"Dawson, P. A., Lan, T. & Rao, A. Bile acid transporters. J. Lipid Res. \n                           50, 2340\u20132357 (2009).","journal-title":"J. Lipid Res."},{"key":"10524_CR13","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00204-013-1118-1","volume":"88","author":"MR McGill","year":"2014","unstructured":"McGill, M. R. et al. Circulating acylcarnitines as biomarkers of mitochondrial dysfunction after acetaminophen overdose in mice and humans. Arch. Toxicol. \n                           88, 391\u2013401 (2014).","journal-title":"Arch. Toxicol."},{"key":"10524_CR14","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.cmet.2012.04.010","volume":"15","author":"DM Muoio","year":"2012","unstructured":"Muoio, D. M. & Neufer, P. D. Lipid-induced mitochondrial stress and insulin action in muscle. Cell Metab. \n                           15, 595\u2013605 (2012).","journal-title":"Cell Metab."},{"key":"10524_CR15","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2013.05.030","volume":"59","author":"D Beyoglu","year":"2013","unstructured":"Beyoglu, D. & Idle, J. R. The metabolomic window into hepatobiliary disease. J. Hepatol. \n                           59, 842\u2013858 (2013).","journal-title":"J. Hepatol."},{"key":"10524_CR16","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1002\/hep.24193","volume":"53","author":"T Matsubara","year":"2011","unstructured":"Matsubara, T. et al. Lithocholic acid disrupts phospholipid and sphingolipid homeostasis leading to cholestasis in mice. Hepatology \n                           53, 1282\u20131293 (2011).","journal-title":"Hepatology"},{"key":"10524_CR17","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/hep.25630","volume":"56","author":"N Tanaka","year":"2012","unstructured":"Tanaka, N., Matsubara, T., Krausz, K. W., Patterson, A. D. & Gonzalez, F. J. Disruption of phospholipid and bile acid homeostasis in mice with nonalcoholic steatohepatitis. Hepatology \n                           56, 118\u2013129 (2012).","journal-title":"Hepatology"},{"key":"10524_CR18","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1007\/s00204-016-1877-6","volume":"91","author":"ZZ Fang","year":"2016","unstructured":"Fang, Z. Z. et al. Role of the lipid-regulated NF-kappaB\/IL-6\/STAT3 axis in alpha-naphthyl isothiocyanate-induced liver injury. Arch. Toxicol. \n                           91, 2235\u20132244 (2016).","journal-title":"Arch. Toxicol."},{"key":"10524_CR19","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/0026-0495(93)90056-T","volume":"42","author":"AP Day","year":"1993","unstructured":"Day, A. P., Feher, M. D., Chopra, R. & Mayne, P. D. The effect of bezafibrate treatment on serum alkaline phosphatase isoenzyme activities. Metabolism. \n                           42, 839\u2013842 (1993).","journal-title":"Metabolism."},{"key":"10524_CR20","first-page":"2757","volume":"9","author":"Y Zhang","year":"2015","unstructured":"Zhang, Y. et al. Combination therapy of fenofibrate and ursodeoxycholic acid in patients with primary biliary cirrhosis who respond incompletely to UDCA monotherapy: a meta-analysis. Drug Des. Devel Ther. \n                           9, 2757\u20132766 (2015).","journal-title":"Drug Des. Devel Ther."},{"key":"10524_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/apt.13465","volume":"43","author":"AC Cheung","year":"2016","unstructured":"Cheung, A. C. et al. Combined ursodeoxycholic acid (UDCA) and fenofibrate in primary biliary cholangitis patients with incomplete UDCA response may improve outcomes. Aliment. Pharmacol. Ther. \n                           43, 283\u2013293 (2016).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10524_CR22","doi-asserted-by":"crossref","first-page":"894","DOI":"10.3748\/wjg.v10.i6.894","volume":"10","author":"K Dohmen","year":"2004","unstructured":"Dohmen, K. et al. Fenofibrate for patients with asymptomatic primary biliary cirrhosis. World J. Gastroenterol. \n                           10, 894\u2013898 (2004).","journal-title":"World J. Gastroenterol."},{"key":"10524_CR23","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/j.1751-2980.2012.00574.x","volume":"13","author":"XF Han","year":"2012","unstructured":"Han, X. F. et al. Efficacy of fenofibrate in Chinese patients with primary biliary cirrhosis partially responding to ursodeoxycholic acid therapy. J. Dig. Dis. \n                           13, 219\u2013224 (2012).","journal-title":"J. Dig. Dis."},{"key":"10524_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2174\/1874192401004010120","volume":"4","author":"EN Liberopoulos","year":"2010","unstructured":"Liberopoulos, E. N., Florentin, M., Elisaf, M. S., Mikhailidis, D. P. & Tsianos, E. Fenofibrate in primary biliary cirrhosis: a pilot study. Open Cardiovasc. Med. J. \n                           4, 120\u2013126 (2010).","journal-title":"Open Cardiovasc. Med. J."},{"key":"10524_CR25","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1002\/hep.26155","volume":"57","author":"NS Ghonem","year":"2013","unstructured":"Ghonem, N. S. & Boyer, J. L. Fibrates as adjuvant therapy for chronic cholestatic liver disease: its time has come. Hepatology \n                           57, 1691\u20131693 (2013).","journal-title":"Hepatology"},{"key":"10524_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-7-44","volume":"7","author":"M Cindoruk","year":"2007","unstructured":"Cindoruk, M. et al. Peroxisome proliferators-activated alpha agonist treatment ameliorates hepatic damage in rats with obstructive jaundice: an experimental study. BMC Gastroenterol. \n                           7, 44 (2007).","journal-title":"BMC Gastroenterol."},{"key":"10524_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/781348","volume":"2013","author":"A El-Sisi","year":"2013","unstructured":"El-Sisi, A., Hegazy, S. & El-Khateeb, E. Effects of three different fibrates on intrahepatic cholestasis experimentally induced in rats. PPAR Res. \n                           2013, 781348 (2013).","journal-title":"PPAR Res."},{"key":"10524_CR28","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.pharmthera.2010.03.005","volume":"126","author":"G Zollner","year":"2010","unstructured":"Zollner, G., Wagner, M. & Trauner, M. Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity. Pharmacol. Ther. \n                           126, 228\u2013243 (2010).","journal-title":"Pharmacol. Ther."},{"key":"10524_CR29","doi-asserted-by":"publisher","first-page":"28947","DOI":"10.1074\/jbc.M002782200","volume":"275","author":"MC Hunt","year":"2000","unstructured":"Hunt, M. C. et al. The peroxisome proliferator-activated receptor alpha (PPARalpha) regulates bile acid biosynthesis. J. Biol. Chem. \n                           275, 28947\u201328953 (2000).","journal-title":"J. Biol. Chem."},{"key":"10524_CR30","doi-asserted-by":"publisher","first-page":"12530","DOI":"10.1074\/jbc.275.17.12530","volume":"275","author":"SK Cheema","year":"2000","unstructured":"Cheema, S. K. & Agellon, L. B. The murine and human cholesterol 7alpha-hydroxylase gene promoters are differentially responsive to regulation by fatty acids mediated via peroxisome proliferator-activated receptor alpha. J. Biol. Chem. \n                           275, 12530\u201312536 (2000).","journal-title":"J. Biol. Chem."},{"key":"10524_CR31","doi-asserted-by":"publisher","first-page":"30559","DOI":"10.1074\/jbc.M203511200","volume":"277","author":"D Jung","year":"2002","unstructured":"Jung, D., Fried, M. & Kullak-Ublick, G. A. Human apical sodium-dependent bile salt transporter gene (SLC10A2) is regulated by the peroxisome proliferator-activated receptor alpha. J. Biol. Chem. \n                           277, 30559\u201330566 (2002).","journal-title":"J. Biol. Chem."},{"key":"10524_CR32","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1161\/hq1101.098228","volume":"21","author":"SM Post","year":"2001","unstructured":"Post, S. M. et al. Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression. Arterioscler. Thromb. Vasc. Biol. \n                           21, 1840\u20131845 (2001).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10524_CR33","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1089\/ars.2006.8.76","volume":"8","author":"HY Cho","year":"2006","unstructured":"Cho, H. Y., Reddy, S. P. & Kleeberger, S. R. Nrf2 defends the lung from oxidative stress. Antioxid. Redox Signal. \n                           8, 76\u201387 (2006).","journal-title":"Antioxid. Redox Signal."},{"key":"10524_CR34","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1096\/fj.03-1127fje","volume":"18","author":"HY Cho","year":"2004","unstructured":"Cho, H. Y., Reddy, S. P., Yamamoto, M. & Kleeberger, S. R. The transcription factor NRF2 protects against pulmonary fibrosis. FASEB J. \n                           18, 1258\u20131260 (2004).","journal-title":"FASEB J."},{"key":"10524_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0003-9861(91)90419-J","volume":"289","author":"PA Watkins","year":"1991","unstructured":"Watkins, P. A., Ferrell, E. V. Jr., Pedersen, J. I. & Hoefler, G. Peroxisomal fatty acid beta-oxidation in HepG2 cells. Arch. Biochem. Biophys. \n                           289, 329\u2013336 (1991).","journal-title":"Arch. Biochem. Biophys."},{"key":"10524_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/srep27239","volume":"6","author":"JC Garc\u00eda- Ca\u00f1averas","year":"2016","unstructured":"Garc\u00eda- Ca\u00f1averas, J. C. et al. A metabolomics cell-based approach for anticipating and investigating drug-induced liver injury. Sci. Rep. \n                           6, 27239 (2016).","journal-title":"Sci. Rep."},{"key":"10524_CR37","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1203\/PDR.0b013e31816ff6f0","volume":"63","author":"S Primassin","year":"2008","unstructured":"Primassin, S., Ter Veld, F., Mayatepek, E. & Spiekerkoetter, U. Carnitine supplementation induceds acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine. Pediatr. Res. \n                           63, 632\u2013637 (2008).","journal-title":"Pediatr. Res."},{"key":"10524_CR38","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1038\/nature07762","volume":"457","author":"A Sreekumar","year":"2009","unstructured":"Sreekumar, A. et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature \n                           457, 910\u2013914 (2009).","journal-title":"Nature"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10524-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10524-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10524-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T09:46:17Z","timestamp":1671788777000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-10524-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,30]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["10524"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-10524-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,30]]},"assertion":[{"value":"12 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9967"}}